Jump Financial LLC Takes $33 Million Position in Astera Labs, Inc. $ALAB

Key Points

• Jump Financial LLC has made a significant investment in Astera Labs, acquiring 553,003 shares valued at approximately $32.99 million, making it the firm's 27th largest holding.
• Astera Labs' stock price has shown substantial growth, with a 149.5% increase in revenue compared to the same quarter last year, and analysts projecting a strong outlook for the company.
• Several hedge funds have also increased their investments in Astera Labs recently, with institutional ownership now at 60.47% of the company's stock.

Jump Financial LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm purchased 553,003 shares of the company's stock, valued at approximately $32,998,000. Astera Labs makes up 0.5% of Jump Financial LLC's investment portfolio, making the stock its 27th largest position. Jump Financial LLC owned 0.34% of Astera Labs as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. NewEdge Advisors LLC purchased a new stake in shares of Astera Labs during the 4th quarter worth about $63,000. Banque Transatlantique SA acquired a new position in shares of Astera Labs during the 4th quarter valued at about $86,000. Emerald Mutual Fund Advisers Trust increased its holdings in shares of Astera Labs by 429.3% during the 4th quarter. Emerald Mutual Fund Advisers Trust now owns 704 shares of the company's stock valued at $93,000 after acquiring an additional 571 shares during the last quarter. Gen Wealth Partners Inc acquired a new position in shares of Astera Labs during the 4th quarter valued at about $105,000. Finally, Sound Income Strategies LLC increased its holdings in shares of Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after acquiring an additional 204 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently commented on ALAB shares. Stifel Nicolaus set a $145.00 price objective on Astera Labs and gave the company a "buy" rating in a report on Monday, August 4th. Northland Securities lowered Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price objective on the stock. in a report on Tuesday, July 22nd. Evercore ISI lifted their price objective on Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, August 6th. Wall Street Zen raised Astera Labs from a "hold" rating to a "buy" rating in a report on Saturday, August 16th. Finally, Susquehanna lifted their price objective on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $129.13.

Insider Transactions at Astera Labs

In related news, CFO Michael Truett Tate sold 500,000 shares of the stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $90.23, for a total transaction of $45,115,000.00. Following the sale, the chief financial officer owned 618,996 shares of the company's stock, valued at $55,852,009.08. This represents a 44.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the sale, the chief operating officer directly owned 5,525,545 shares in the company, valued at $939,453,160.90. This represents a 4.82% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 2,385,416 shares of company stock worth $298,063,981. Company insiders own 12.50% of the company's stock.

Astera Labs Stock Performance

ALAB traded down $4.94 on Monday, hitting $174.15. 3,500,068 shares of the company were exchanged, compared to its average volume of 4,966,220. The stock's fifty day moving average is $123.97 and its 200-day moving average is $92.74. The company has a market cap of $28.95 billion, a PE ratio of 310.98, a PEG ratio of 4.54 and a beta of 1.39. Astera Labs, Inc. has a 12 month low of $36.85 and a 12 month high of $199.47.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The firm had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business's revenue for the quarter was up 149.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.